GN Store Nord A/S (CPH:GN)
111.05
+2.85 (2.63%)
At close: Jan 30, 2026
GN Store Nord Market Cap
GN Store Nord has a market cap or net worth of 16.17 billion as of January 30, 2026. Its market cap has decreased by -10.37% in one year.
Market Cap
16.17B
Enterprise Value
26.40B
Revenue
17.12B
Ranking
n/a
PE Ratio
23.93
Stock Price
111.05
Market Cap Chart
Since March 30, 1993, GN Store Nord's market cap has increased from 330.14M to 16.17B, an increase of 4,797.93%. That is a compound annual growth rate of 12.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 16.17B | 4.03% |
| Dec 30, 2025 | 15.54B | -20.19% |
| Dec 30, 2024 | 19.48B | -22.12% |
| Dec 29, 2023 | 25.01B | 22.33% |
| Dec 30, 2022 | 20.44B | -61.08% |
| Dec 30, 2021 | 52.52B | -16.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.69T |
| Genmab | 126.22B |
| Coloplast | 122.01B |
| Demant | 47.16B |
| H. Lundbeck | 41.85B |
| Zealand Pharma | 28.85B |
| Ambu A/S | 22.70B |
| Bavarian Nordic | 15.16B |